{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:10:04Z","timestamp":1781827804128,"version":"3.54.5"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31771466"],"award-info":[{"award-number":["31771466"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB38040100"],"award-info":[{"award-number":["XDB38040100"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Internal tandem duplication (ITD) of FMS-like tyrosine kinase 3 (FLT3-ITD) constitutes an independent indicator of poor prognosis in acute myeloid leukaemia (AML). AML with FLT3-ITD usually presents with poor treatment outcomes, high recurrence rate and short overall survival. Currently, polymerase chain reaction and capillary electrophoresis are widely adopted for the clinical detection of FLT3-ITD, whereas the length and mutation frequency of ITD are evaluated using fragment analysis. With the development of sequencing technology and the high incidence of FLT3-ITD mutations, a multitude of bioinformatics tools and pipelines have been developed to detect FLT3-ITD using next-generation sequencing data. However, systematic comparison and evaluation of the methods or software have not been performed. In this study, we provided a comprehensive review of the principles, functionality and limitations of the existing methods for detecting FLT3-ITD. We further compared the qualitative and quantitative detection capabilities of six representative tools using simulated and biological data. Our results will provide practical guidance for researchers and clinicians to select the appropriate FLT3-ITD detection tools and highlight the direction of future developments in this field. Availability: A Docker image with several programs pre-installed is available at https:\/\/github.com\/niu-lab\/docker-flt3-itd to facilitate the application of FLT3-ITD detection tools.<\/jats:p>","DOI":"10.1093\/bib\/bbab099","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T12:12:00Z","timestamp":1615378320000},"source":"Crossref","is-referenced-by-count":14,"title":["Comprehensive review and evaluation of computational methods for identifying <i>FLT3<\/i>-internal tandem duplication in acute myeloid leukaemia"],"prefix":"10.1093","volume":"22","author":[{"given":"Danyang","family":"Yuan","sequence":"first","affiliation":[{"name":"Computer Network Information Center, Chinese Academy of Sciences. She is mainly engaged in leukaemia-related bioinformatics and cancer genomics research. Her affiliation is with Computer Network Information Center, Chinese Academy of Sciences, University of the Chinese Academy of Sciences, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"He","sequence":"additional","affiliation":[{"name":"Computer Network Information Center, Chinese Academy of Sciences. She is mainly engaged in research related to the cancer genome and construction of the Chinese Cancer Genome Database. Her affiliation is with Computer Network Information Center, Chinese Academy of Sciences, University of the Chinese Academy of Sciences, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyin","family":"Han","sequence":"additional","affiliation":[{"name":"Computer Network Information Center, Chinese Academy of Sciences. He is mainly engaged in cancer genomics research focusing on the precise detection of tumour immunotherapy biomarkers. His affiliation is with Computer Network Information Center, Chinese Academy of Sciences, University of the Chinese Academy of Sciences, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Yang","sequence":"additional","affiliation":[{"name":"Vice Director of the Laboratory of ChosenMed Technology (Beijing) Co., Ltd. She is mainly engaged in research regarding solid tumours and haematologic malignancy using multiple approaches, including next-generation sequencing. Her affiliation is with ChosenMed Technology (Beijing) Co., Ltd., Beijing 100176, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[{"name":"bioinformatics analysis engineer of ChosenMed Technology (Beijing) Co., Ltd. She is mainly engaged in the collection of biological information and analysis of genomic and cancer data or other biological information. Her affiliation is with ChosenMed Technology (Beijing) Co., Ltd., Beijing 100176, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Computer Network Information Center, Chinese Academy of Sciences. Her research mainly focuses on the cancer genome and bioinformatics. Her affiliation is with Computer Network Information Center, Chinese Academy of Sciences, University of the Chinese Academy of Sciences, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Luan","sequence":"additional","affiliation":[{"name":"Computer Network Information Center, Chinese Academy of Sciences. She is mainly engaged in researching cancers of unknown primary sites (CUP) based on deep learning. Her affiliation is with Computer Network Information Center, Chinese Academy of Sciences, University of the Chinese Academy of Sciences, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Li","sequence":"additional","affiliation":[{"name":"Computer Network Information Center, Chinese Academy of Sciences. Her research interests include high-performance computing and bioinformatics. Her affiliation is with Computer Network Information Center, Chinese Academy of Sciences, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"He","sequence":"additional","affiliation":[{"name":"George Washington University. She is currently researching at the Computer Network Information Center, Chinese Academy of Sciences. Her research interests include biostatistics and computational statistics. Her affiliation is with Computer Network Information Center, Chinese Academy of Sciences, Beijing 100190, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Duan","sequence":"additional","affiliation":[{"name":"Laboratory of ChosenMed Technology (Beijing) Co., Ltd. She is mainly engaged in the research of solid tumours and haematologic malignancies using multiple approaches, including next-generation sequencing. Her affiliation is with ChosenMed Technology (Beijing) Co., Ltd., Beijing 100176, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Wang","sequence":"additional","affiliation":[{"name":"Harbin Medical University. He is now the Chief Medical Officer of ChosenMed Technology (Beijing). His research mainly focuses on the mining and verification of molecular markers for tumour therapy. His affiliation is with ChosenMed Technology (Beijing) Co., Ltd., Beijing 100176, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Zhou","sequence":"additional","affiliation":[{"name":"CTO of ChosenMed Technology (Beijing) Co., Ltd. He is mainly engaged in the development of new molecular diagnostics technologies in genetic testing. His affiliation is with ChosenMed Technology (Beijing) Co., Ltd., Beijing 100176, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujun","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Haematology, The First Hospital of Jilin University. Her research mainly focuses on the experimental and clinical research of malignant haematological disorders and haematopoietic stem cell transplantation. Her affiliation is with Department of Haematology, The First Hospital of Jilin University, Changchun 130021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beifang","family":"Niu","sequence":"additional","affiliation":[{"name":"Computer Network Information Center, Chinese Academy of Sciences. His research interests include cancer genomics, metagenomics, and the development of computational tools for working with data from next-generation sequencing technologies. His affiliation is with Computer Network Information Center, Chinese Academy of Sciences, University of the Chinese Academy of Sciences, Beijing 100190, China, ChosenMed Technology (Beijing) Co., Ltd., Beijing 100176, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"key":"2021090815525412200_ref1","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","article-title":"Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project","volume":"116","author":"Sant","year":"2010","journal-title":"Blood"},{"key":"2021090815525412200_ref2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12032-017-0970-x","article-title":"Ch\u00e1vez-Valencia V. FLT3\u2013ITD and its current role in acute myeloid leukaemia","volume":"34","author":"Lagunas-Rangel","year":"2017","journal-title":"Med Oncol"},{"key":"2021090815525412200_ref3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.beha.2019.05.003","article-title":"Can we incorporate MRD assessment into clinical practice in AML?","volume":"32","author":"Ossenkoppele","year":"2019","journal-title":"Best Pract Res Clin Haematol"},{"key":"2021090815525412200_ref4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2021090815525412200_ref5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(12)61727-9","article-title":"Acute myeloid leukaemia in adults","volume":"381","author":"Ferrara","year":"2013","journal-title":"Lancet"},{"key":"2021090815525412200_ref6","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and Epigenomic landscapes of adult De novo acute myeloid Leukemia","volume":"368","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"New Engl J Med"},{"key":"2021090815525412200_ref7","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid Leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"New Engl J Med"},{"key":"2021090815525412200_ref8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"2021090815525412200_ref9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"2021090815525412200_ref10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1158\/1535-7163.MCT-16-0876","article-title":"FLT3 inhibitors in acute myeloid Leukemia: current status and future directions","volume":"16","author":"Larrosa-Garcia","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"2021090815525412200_ref11","first-page":"1911","article-title":"Internal tandem duplication of the flt3 gene found in acute myeloid leukemia","volume":"10","author":"Nakao","year":"1996","journal-title":"Leukemia"},{"key":"2021090815525412200_ref12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/asheducation-2006.1.178","article-title":"FLT3 mutations: biology and treatment","volume":"2006","author":"Small","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2021090815525412200_ref13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41375-018-0357-9","article-title":"Targeting FLT3 mutations in AML: review of current knowledge and evidence","volume":"33","author":"Daver","year":"2019","journal-title":"Leukemia"},{"key":"2021090815525412200_ref14","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1080\/10428194.2017.1399312","article-title":"The importance of FLT3 mutational analysis in acute myeloid leukemia","volume":"59","author":"Patnaik","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"2021090815525412200_ref15","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.2147\/CMAR.S194523","article-title":"Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis","volume":"11","author":"Huang","year":"2019","journal-title":"Cancer Manag Res"},{"key":"2021090815525412200_ref16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00432-016-2290-5","article-title":"Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment","volume":"143","author":"Fleischmann","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"2021090815525412200_ref17","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2009-03-209999","article-title":"Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome","volume":"114","author":"Kayser","year":"2009","journal-title":"Blood"},{"key":"2021090815525412200_ref18","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/sj.leu.2403099","article-title":"FLT3: ITDoes matter in leukemia","volume":"17","author":"Levis","year":"2003","journal-title":"Leukemia"},{"key":"2021090815525412200_ref19","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1002\/cncr.27571","article-title":"Impact of numerical variation in FMS-like tyrosine kinase receptor 3 internal tandem duplications on clinical outcome in normal karyotype acute myelogenous leukemia","volume":"118","author":"Borthakur","year":"2012","journal-title":"Cancer"},{"key":"2021090815525412200_ref20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/leu.2011.97","article-title":"Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia","volume":"25","author":"Schnittger","year":"2011","journal-title":"Leukemia"},{"key":"2021090815525412200_ref21","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood-2007-08-109090","article-title":"The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia","volume":"111","author":"Gale","year":"2008","journal-title":"Blood"},{"key":"2021090815525412200_ref22","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1038\/bcj.2015.61","article-title":"Quantitative fragment analysis of FLT3-ITD efficiently identifying poor prognostic group with high mutant allele burden or long ITD length","volume":"5","author":"Kim","year":"2015","journal-title":"Blood Cancer J"},{"key":"2021090815525412200_ref23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1525-1578(10)60458-8","article-title":"Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assay","volume":"5","author":"Murphy","year":"2003","journal-title":"J Mol Diagn"},{"key":"2021090815525412200_ref24","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144195","article-title":"The prognosis predictive value of FMS-like tyrosine kinase 3-internal tandem duplications mutant allelic ratio (FLT3-ITD MR) in patients with acute myeloid leukemia detected by GeneScan","volume":"726","author":"Lyu","year":"2020","journal-title":"Gene"},{"key":"2021090815525412200_ref25","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1182\/blood-2014-05-578070","article-title":"Differential impact of allelic ratio and insertion site in FLT3-ITD\u2013positive AML with respect to allogeneic transplantation","volume":"124","author":"Schlenk","year":"2014","journal-title":"Blood"},{"key":"2021090815525412200_ref26","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2005-08-3453","article-title":"Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia","volume":"107","author":"Stirewalt","year":"2006","journal-title":"Blood"},{"key":"2021090815525412200_ref27","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2008-01-117770","article-title":"Structural and numerical variation of FLT3\/ITD in pediatric AML","volume":"111","author":"Meshinchi","year":"2008","journal-title":"Blood"},{"key":"2021090815525412200_ref28","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3324\/haematol.2018.191809","article-title":"Impact of FLT3-ITD length on prognosis of acute myeloid leukemia","volume":"104","author":"Liu","year":"2019","journal-title":"Haematologica"},{"key":"2021090815525412200_ref29","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3109\/10428194.2013.850163","article-title":"Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort","volume":"55","author":"Koszarska","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"2021090815525412200_ref30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41408-020-0318-1","article-title":"Impact of numerical variation, allele burden, mutation length and co-occurring mutations on the efficacy of tyrosine kinase inhibitors in newly diagnosed FLT3- mutant acute myeloid leukemia","volume":"10","author":"Abou Dalle","year":"2020","journal-title":"Blood Cancer J"},{"key":"2021090815525412200_ref31","first-page":"2694","article-title":"Validation of the ELN 2017 classification for AML with intermediate risk cytogenetics with or without NPM1 -mutations and high or low ratio FLT3-ITD s","volume":"130","author":"Schetelig","year":"2017","journal-title":"Blood"},{"key":"2021090815525412200_ref32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1179\/1607845413Y.0000000085","article-title":"Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia","volume":"19","author":"Shamaa","year":"2014","journal-title":"Hematology"},{"key":"2021090815525412200_ref33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ejmhg.2018.04.006","article-title":"FLT3 receptor\/CD135 expression by flow cytometry in acute myeloid leukemia: relation to FLT3 gene mutations and mRNA transcripts. Egypt","volume":"19","author":"Mekawy","year":"2018","journal-title":"J Medical Hum Genet"},{"key":"2021090815525412200_ref34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41379-019-0359-9","article-title":"Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis","volume":"33","author":"He","year":"2020","journal-title":"Mod Pathol"},{"key":"2021090815525412200_ref35","first-page":"251","article-title":"Detection and quantification of FLT3 internal tandem duplication mutations do not vary significantly between whole blood and blast-enriched samples","volume":"153","author":"Schumacher","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"2021090815525412200_ref36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s13353-015-0336-z","article-title":"Sachadyn PJJoag. A simple modification of PCR thermal profile applied to evade persisting contamination","volume":"57","author":"Banasik","year":"2016","journal-title":"J Appl Genet"},{"key":"2021090815525412200_ref37","doi-asserted-by":"crossref","first-page":"30128","DOI":"10.18632\/oncotarget.25729","article-title":"Clonal heterogeneity of FLT3-ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemia","volume":"9","author":"Schranz","year":"2018","journal-title":"Oncotarget"},{"key":"2021090815525412200_ref38","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3343\/alm.2019.39.3.327","article-title":"FLT3 internal tandem duplication in patients with acute myeloid leukemia is readily detectable in a single next-generation sequencing assay using the pindel algorithm","volume":"39","author":"Kim","year":"2019","journal-title":"Ann Lab Med"},{"key":"2021090815525412200_ref39","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/gcc.21955","article-title":"Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations","volume":"51","author":"Thol","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"key":"2021090815525412200_ref40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jmoldx.2012.08.001","article-title":"Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data","volume":"15","author":"Spencer","year":"2013","journal-title":"J Mol Diagn"},{"key":"2021090815525412200_ref41","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.4333","article-title":"Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia","volume":"6","author":"Bibault","year":"2015","journal-title":"Oncotarget"},{"key":"2021090815525412200_ref42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3324\/haematol.2018.194258","article-title":"Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing","volume":"104","author":"Elisabeth","year":"2019","journal-title":"Haematologica"},{"key":"2021090815525412200_ref43","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","article-title":"Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads","volume":"25","author":"Ye","year":"2009","journal-title":"Bioinformatics"},{"key":"2021090815525412200_ref44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13000-016-0456-8","article-title":"Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms","volume":"11","author":"Au","year":"2016","journal-title":"Diagn Pathol"},{"key":"2021090815525412200_ref45","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/s41375-019-0483-z","article-title":"getITD for FLT3-ITD-based MRD monitoring in AML","volume":"33","author":"Bl\u00e4tte","year":"2019","journal-title":"Leukemia"},{"key":"2021090815525412200_ref46","doi-asserted-by":"crossref","first-page":"giaa089","DOI":"10.1093\/gigascience\/giaa089","article-title":"ScanITD: detecting internal tandem duplication with robust variant allele frequency estimation","volume":"9","author":"Wang","year":"2020","journal-title":"Gigascience"},{"key":"2021090815525412200_ref47","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jmoldx.2020.06.006","article-title":"Targeted informatics for optimal detection, characterization, and quantification of FLT3 internal tandem duplications across multiple next-generation sequencing platforms","volume":"22","author":"Tsai","year":"2020","journal-title":"J Mol Diagn"},{"key":"2021090815525412200_ref48","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1093\/nar\/gku1211","article-title":"BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers","volume":"43","author":"Abo","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2021090815525412200_ref49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/bioinformatics\/btu593","article-title":"Genomon ITDetector: a tool for somatic internal tandem duplication detection from cancer genome sequencing data","volume":"31","author":"Chiba","year":"2014","journal-title":"Bioinformatics"},{"key":"2021090815525412200_ref50","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12859-016-1031-8","article-title":"ITD assembler: an algorithm for internal tandem duplication discovery from short-read sequencing data","volume":"17","author":"Rustagi","year":"2016","journal-title":"BMC Bioinformatics"},{"key":"2021090815525412200_ref51","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jmoldx.2015.06.005","article-title":"Amplicon Indel hunter is a novel bioinformatics tool to detect large somatic insertion\/deletion mutations in amplicon-based next-generation sequencing data","volume":"17","author":"Kadri","year":"2015","journal-title":"J Mol Diagn"},{"key":"2021090815525412200_ref52","volume-title":"An optimized NGS workflow for detection of FLT3 internal tandem duplication (ITD) in AML samples. In: Proceedings of the American Association for Cancer Research Annual Meeting 2018, Chicago, IL, 2018. Abstract 4522","author":"Wang"},{"key":"2021090815525412200_ref53","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/bloodadvances.2018015925","article-title":"A next-generation sequencing\u2013based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations","volume":"2","author":"Levis","year":"2018","journal-title":"Blood Adv"},{"key":"2021090815525412200_ref54","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with burrows\u2013wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2021090815525412200_ref55","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/humu.22825","article-title":"Evaluation of hybridization capture versus amplicon-based methods for whole-exome sequencing","volume":"36","author":"Samorodnitsky","year":"2015","journal-title":"Hum Mutat"},{"key":"2021090815525412200_ref56","article-title":"Comprehensive fundamental somatic variant calling and quality management strategies for human cancer genomes","author":"He","year":"2020","journal-title":"Brief Bioinform"},{"key":"2021090815525412200_ref57","volume-title":"Babraham Bioinformatics","author":"Andrews","year":"2010"},{"key":"2021090815525412200_ref58","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/5\/bbab099\/40261800\/bbab099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/5\/bbab099\/40261800\/bbab099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T19:02:43Z","timestamp":1631127763000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab099\/6225087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab099","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,4,13]]},"article-number":"bbab099"}}